Tilo Biedermann

Biedersteiner Str. 29
Munich, BY 80802, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 497 publications

Cabozantinib-associated therapy-refractory lower-leg ulcers in metastatic renal cell carcinoma.

Cabozantinib-associated therapy-refractory lower-leg ulcers in metastatic renal cell carcinoma.

Journal: JAAD case reports

Published: September 01, 2026

Treatment of psoriasis as a systemic disease

Treatment of psoriasis as a systemic disease

Journal: MMW Fortschritte der Medizin

Published: May 12, 2026

Patient Expectations and Perceived Treatment Benefit in Dermatology: A Sex-specific Analysis in Routine Dermatological Care.

Patient Expectations and Perceived Treatment Benefit in Dermatology: A Sex-specific Analysis in Routine Dermatological Care.

Journal: Acta dermato-venereologica

Published: May 07, 2026

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

Journal: Allergologie select

Published: May 06, 2026

Non-communicable inflammatory skin diseases comprise clinically meaningful distinct endotypes as identified by non-hypothesized integration of phenotypic and transcriptome data.

Non-communicable inflammatory skin diseases comprise clinically meaningful distinct endotypes as identified by non-hypothesized integration of phenotypic and transcriptome data.

Journal: The Journal of allergy and clinical immunology

Published: April 16, 2026

Improvement of Depressive and Fatigue Symptoms under Dupilumab Therapy in Atopic Dermatitis Patients: Results from the TREATgermany Registry.

Improvement of Depressive and Fatigue Symptoms under Dupilumab Therapy in Atopic Dermatitis Patients: Results from the TREATgermany Registry.

Journal: Acta dermato-venereologica

Published: April 16, 2026

Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis.

Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis.

Journal: Acta dermato-venereologica

Published: March 26, 2026

Patient treatment needs in atopic dermatitis: A real-world cohort study.

Patient treatment needs in atopic dermatitis: A real-world cohort study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 15, 2026

Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 years.

Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 years.

Journal: The Journal of dermatological treatment

Published: March 12, 2026

Title Not Found

Title Not Found

Journal: Dermatologie (Heidelberg, Germany)

Published: February 16, 2026

Demonstration of Gliadin Penetration into the Epidermis by Tape Stripping as Prerequisite for Percutaneous Sensitisation in Wheat Allergy.

Demonstration of Gliadin Penetration into the Epidermis by Tape Stripping as Prerequisite for Percutaneous Sensitisation in Wheat Allergy.

Journal: International journal of molecular sciences

Published: February 08, 2026

Addictions in Hidradenitis Suppurativa: A Cross-Sectional Pilot Study.

Addictions in Hidradenitis Suppurativa: A Cross-Sectional Pilot Study.

Journal: Dermatology and therapy

Published: February 05, 2026

Showing 1-12 of 497

Last Updated: 09/26/2026